News about Industrial talks

Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities

Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities

Agilent Advanced Therapeutics offers CDMO services spanning oligonucleotides, microbial fermentation, complex chemistry, bioreagents, highly potent APIs, and cell line development, providing integrated end-to-end support from discovery and process development to clinical and commercial manufacturing.

Industrial talks | 12/03/2026 | By News Bureau 108

AI Imaging Biomarker Shows Promise in Predicting Immunotherapy Response in Non-Small Cell Lung Cancer Patients

AI Imaging Biomarker Shows Promise in Predicting Immunotherapy Response in Non-Small Cell Lung Cancer Patients

A multi-institutional study published in the Journal for ImmunoTherapy of Cancer finds that an AI-based imaging biomarker can predict immunotherapy outcomes and detect early treatment response in lung cancer patients.

Industrial talks | 11/03/2026 | By News Bureau 112

Seaport Therapeutics Secures Up to USD 15 Million ARPA-H Grant to Advance Lymphatic Targeted Therapy for Metabolic Disease and Pancreatic Cancer

Seaport Therapeutics Secures Up to USD 15 Million ARPA-H Grant to Advance Lymphatic Targeted Therapy for Metabolic Disease and Pancreatic Cancer

Seaport Therapeutics receives up to USD 15 million from ARPA-H to develop GlyphCele, a lymphatic-targeted oral therapy designed to treat metabolic disease and pancreatic cancer by restoring gut lymphatic function.

Industrial talks | 06/03/2026 | By News Bureau 162

Pharmacy Council of India Announces 2026 Theme for National Pharmacy Education Day

Pharmacy Council of India Announces 2026 Theme for National Pharmacy Education Day

The Pharmacy Council of India (PCI) has unveiled the official theme for Pharma Anveshan 2026, an event to be organised nationwide by pharmacy institutions as part of National Pharmacy Education Day celebrations on March 6, 2026.

Industrial talks | 04/03/2026 | By Darshana 843

Pfizer Chief Criticises FDA Vaccine Unit Leadership and Decision-Making

Pfizer Chief Criticises FDA Vaccine Unit Leadership and Decision-Making

Pfizer Chief Executive Officer Albert Bourla has publicly raised concerns about the leadership of the US Food and Drug Administration’s vaccine and biologics division, citing internal discord and recent regulatory decisions as problematic.

Industrial talks | 03/03/2026 | By Darshana 149

Dr Jitendra Singh Proposes India-Delaware Biomanufacturing Working Group

Dr Jitendra Singh Proposes India-Delaware Biomanufacturing Working Group

Dr Jitendra Singh proposed an India-Delaware Biomanufacturing Working Group to boost biotech collaboration, highlighting startup and R&D linkages. He also stressed supply chain resilience and regulatory cooperation during India-US talks to strengthen innovation, manufacturing and strategic life sciences ties.

Industrial talks | 03/03/2026 | By News Bureau 119

ACC Extends Dr Rajeev Singh Raghuvanshi's appointment as Drugs Controller (India) for One Year

ACC Extends Dr Rajeev Singh Raghuvanshi's appointment as Drugs Controller (India) for One Year

Dr Rajeev Singh Raghuvanshi receives a second one-year extension as head of CDSCO amid ongoing regulatory reforms and Schedule M implementation.

Industrial talks | 02/03/2026 | By News Bureau 544

Argo Biopharma to Present Phase II Interim Data on BW-20805 for HAE at AAAAI 2026

Argo Biopharma to Present Phase II Interim Data on BW-20805 for HAE at AAAAI 2026

Argo Biopharma’s investigational siRNA therapy BW-20805 showed sustained reduction in hereditary angioedema attack rates and plasma prekallikrein levels, with favorable safety, in Phase II interim data selected for AAAAI 2026.

Industrial talks | 27/02/2026 | By News Bureau 185

Medicines and Healthcare products Regulatory Agency Approves Inluriyo for Advanced ER-Positive Breast Cancer

Medicines and Healthcare products Regulatory Agency Approves Inluriyo for Advanced ER-Positive Breast Cancer

The UK regulator has approved Inluriyo (imlunestrant tosylate) for adults with ER-positive, HER2-negative advanced breast cancer with ESR1 mutations after prior hormone therapy failure.

Industrial talks | 26/02/2026 | By News Bureau 151

Boehringer Ingelheim Appoints Meenal Gauri as Managing Director for India and South Asia

Boehringer Ingelheim Appoints Meenal Gauri as Managing Director for India and South Asia

Boehringer Ingelheim has named Meenal Gauri as Managing Director India, effective January 12, 2026, overseeing operations across five South Asian markets and joining the company’s India board.

Industrial talks | 25/02/2026 | By News Bureau 172

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members